Understanding the Mechanisms of Diastolic Dysfunction
Heart Failure With Preserved Ejection Fraction, Healthy
About this trial
This is an interventional diagnostic trial for Heart Failure With Preserved Ejection Fraction focused on measuring diastolic dysfunction, mechanism, MRI magnetic resonance imaging, ejection fraction
Eligibility Criteria
Inclusion Criteria:
Healthy volunteers
1. Healthy adults
Patients with Heart Failure with Preserved Ejection Fraction
- Patient scheduled for catheterization at UCLA Medical Center
- Ejection fraction >/= 50%
- Signs and symptoms of heart failure
- Excluded other potential non-cardiac etiologies of heart failure
Exclusion Criteria:
Healthy volunteers
- Known medical condition that impacts heart health
- Contraindications to MRI (e.g., pacemaker/ICD, or claustrophobia)
Patients with Heart Failure with Preserved Ejection Fraction
Exclusion Criteria:
- Contraindications to MRI (e.g., pacemaker/ICD, or claustrophobia)
- Prior MI or history of PCI/CABG
- Worse than mild valvular disease
- Any indication for ICD implantation
- Contraindication to MRI contrast agents or eGRF <30 ml/min/1.73m2 or MRI exams (e.g., pacemaker/ICD or claustrophobia).
- Atrial fibrillation or unstable cardiac rhythm
Sites / Locations
- University of California Los Angeles
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Group 1
Group 2
Group 3
Group 1 includes 25 healthy subjects recruited in Year 1 to undergo cardiac MRI without contrast.
Group 2 includes 25 healthy subjects recruited in Year 2 to undergo cardiac MRI without contrast.
Group 3 includes 33 patients with Heart Failure with Preserved Ejection Fraction (HFpEF) who will undergo cardiac MRI at baseline and at six months to assess diagnostic sensitivity of MRI measurement.